Breaking News Instant updates and real-time market news.

AGRX

Agile Therapeutics

$3.37

-0.1 (-2.88%)

14:16
05/07/17
05/07
14:16
05/07/17
14:16

Agile Therapeutics reports additional data from Phase 3 Twirla study

Agile Therapeutics announced the presentation of additional results of its Phase 3 SECURE trial of its investigational low-dose combination hormone contraceptive patch, Twirla. The summary of SECURE clinical trial results, which included new data on the bleeding profile of clinical trial subjects, was presented at the Annual Clinical and Scientific Meeting of the American Congress of Obstetricians and Gynecologists. Regarding the bleeding profile, analyses demonstrated that unscheduled bleeding/spotting days per month decreased from a mean of 3.1 days in Cycle 1 to 1.6 days in Cycle 13. In addition, scheduled bleeding/spotting remained consistent during all cycles, with a reported mean of 3.1 to 3.7 days per month. "We are pleased with the results of the SECURE trial and believe our study may set a new standard for hormonal contraceptive studies. Our study entry criteria resulted in the inclusion of a real-world study population, including women who have frequently been underrepresented in past contraceptive studies," noted Agile.

AGRX Agile Therapeutics
$3.37

-0.1 (-2.88%)

01/04/17
JANY
01/04/17
NO CHANGE
Target $15
JANY
Buy
Selloff an overreaction to Agile Therapeutics data, says Janney Capital
Janney Capital analyst Ken Trbovich contends that the market over reacted to the Pearl Index reported by Agile Therapeutics from its Phase 3 SECURE clinical trial of Twirla, noting that the contraceptive patch's reported PI is greater than the reference set by the product with the highest approved PI. As trials become more representative of real-world populations, PI has consistently increased in FDA-approved products over the past 35 years, said Trbovich, who keeps a Buy rating on Agile and argues that Twirla can still gain FDA approval.
01/04/17
WBLR
01/04/17
NO CHANGE
WBLR
Outperform
William Blair thinks Agile approval 'not out of the question'
While the Pearl score data in last night's Phase 3 SECURE trial was below expectations, there is not a zero percent probability of approval for Agile Therapeutics' Twirla upon resubmission, William Blair analyst Tim Lugo tells investors in a research note. The data suggest a less effective contraception than its peers, but Twirla has a potential route for approval considering the product's safety versus Ortho Evra and known issues with running contraception trials, the analyst contends. He believes the probability of approval is likely under 50%, however. Lugo keeps an Outperform rating on shares of Agile with the stock trading down 61% to $1.97 in the pre-market.
01/27/17
RBCM
01/27/17
NO CHANGE
RBCM
Agile Therapeutics shares undervalued, says RBC Capital
After meeting with Agile Therapeutics' management, RBC Capital analyst Randall Stanicky believes that the stock does not "appropriately price in" a possible rally in the shares. The analyst says that the company has a "solid case" for FDA approval of its lead contraceptive patch, Twirla, He adds that Agile could be acquired if the patch is approved in Q4, in-line with the company's target. The analyst keeps an $8 price target and an Outperform rating on the shares. .
03/06/17
03/06/17
NO CHANGE

FBR sees 'prime' merger environment for biotechs under Trump
Potential tax reform and FDA policy changes under President Trump could "prime the pump" for acquisitions of clinical-stage biotech companies by Big Pharma, FBR Capital analysts led by Chris Meekins tell investors in a research note. These police moves, coupled with the repeal of some taxes associated with the Affordable Care Act, are likely to increase funds for companies looking to make acquisitions, the analysts contend. Within its coverage universe, FBR sees TESARO (TSRO), Agile Therapeutics (AGRX), Kite Pharma (KITE), Juno Therapeutics (JUNO), Acceleron Pharma (XLRN), Abeona Therapeutics (ABEO), Aurinia Pharmaceuticals (AUPH), Geron (GERN) and Genocea Biosciences (GNCA) as "primary targets for those looking to make acquisitions."

TODAY'S FREE FLY STORIES

CDAY

Ceridian

$34.31

-0.885 (-2.51%)

05:16
05/23/18
05/23
05:16
05/23/18
05:16
Recommendations
Ceridian analyst commentary  »

Ceridian reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDSO

Medidata

$75.53

-0.45 (-0.59%)

05:11
05/23/18
05/23
05:11
05/23/18
05:11
Recommendations
Medidata analyst commentary  »

Medidata price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

VIRT

Virtu Financial

$29.10

-0.7 (-2.35%)

05:03
05/23/18
05/23
05:03
05/23/18
05:03
Initiation
Virtu Financial initiated  »

Virtu Financial initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KRO

Kronos Worldwide

$24.77

-0.165 (-0.66%)

04:59
05/23/18
05/23
04:59
05/23/18
04:59
Upgrade
Kronos Worldwide rating change  »

Kronos Worldwide upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DSW

DSW

$25.64

0.04 (0.16%)

, JWN

Nordstrom

$45.79

-0.05 (-0.11%)

04:56
05/23/18
05/23
04:56
05/23/18
04:56
Downgrade
DSW, Nordstrom rating change  »

DSW downgraded to Hold…

DSW

DSW

$25.64

0.04 (0.16%)

JWN

Nordstrom

$45.79

-0.05 (-0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

PLAB

Photronics

$9.05

0.6 (7.10%)

04:55
05/23/18
05/23
04:55
05/23/18
04:55
Conference/Events
Photronics to hold an analyst and investor event »

Analyst and Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

TMO

Thermo Fisher

$217.88

1.2 (0.55%)

04:55
05/23/18
05/23
04:55
05/23/18
04:55
Conference/Events
Thermo Fisher to host analyst meeting »

Analyst meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 23

    May

CAFD

8point3 Energy

$12.19

(0.00%)

04:55
05/23/18
05/23
04:55
05/23/18
04:55
Conference/Events
8point3 Energy to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

WST

West Pharmaceutical

$90.09

-0.04 (-0.04%)

04:55
05/23/18
05/23
04:55
05/23/18
04:55
Conference/Events
West Pharmaceutical management to meet with Jefferies »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 19

    Jun

FMBI

First Midwest

$26.40

0.25 (0.96%)

04:55
05/23/18
05/23
04:55
05/23/18
04:55
Conference/Events
First Midwest management to meet with Piper Jaffray »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

SRDX

Surmodics

$49.10

0.8 (1.66%)

04:55
05/23/18
05/23
04:55
05/23/18
04:55
Conference/Events
Surmodics management to meet with Barrington »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 19

    Jun

  • 20

    Jun

  • 25

    Jun

  • 26

    Jun

OTEX

OpenText

$34.21

0.11 (0.32%)

04:55
05/23/18
05/23
04:55
05/23/18
04:55
Conference/Events
OpenText management to meet with Benchmark »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

04:55
05/23/18
05/23
04:55
05/23/18
04:55
General news
Breaking General news story  »

FOMC Minutes to be…

WD

Walker & Dunlop

$56.00

-0.1 (-0.18%)

04:55
05/23/18
05/23
04:55
05/23/18
04:55
Conference/Events
Walker & Dunlop management to meet with JMP Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 24

    May

  • 31

    May

WWE

WWE

$56.88

-0.98 (-1.69%)

04:55
05/23/18
05/23
04:55
05/23/18
04:55
Conference/Events
WWE management to meet with MKM Partners »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

BMCH

BMC Stock Holdings

$19.75

-0.7 (-3.42%)

04:55
05/23/18
05/23
04:55
05/23/18
04:55
Conference/Events
BMC Stock Holdings management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 24

    May

LOGI

Logitech

$40.86

0.15 (0.37%)

04:55
05/23/18
05/23
04:55
05/23/18
04:55
Conference/Events
Logitech management to meet with Citi »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

04:55
05/23/18
05/23
04:55
05/23/18
04:55
General news
Breaking General news story  »

Minneapolis Federal…

MTOR

Meritor

$21.94

-0.2 (-0.90%)

04:55
05/23/18
05/23
04:55
05/23/18
04:55
Conference/Events
Meritor management to meet with RBC Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 13

    Jun

GGG

Graco

$46.70

-0.64 (-1.35%)

04:55
05/23/18
05/23
04:55
05/23/18
04:55
Conference/Events
Graco management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

SSRM

SSR Mining

$10.28

-0.02 (-0.19%)

04:55
05/23/18
05/23
04:55
05/23/18
04:55
Conference/Events
SSR Mining management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

NVEE

NV5 Global

$60.05

-0.55 (-0.91%)

04:55
05/23/18
05/23
04:55
05/23/18
04:55
Conference/Events
NV5 Global management to meet with Lake Street »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 09

    Jun

  • 12

    Jun

  • 13

    Jun

QTM

Quantum

$3.65

0.025 (0.69%)

04:55
05/23/18
05/23
04:55
05/23/18
04:55
Conference/Events
Quantum management to meet with Lake Street »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 29

    May

WERN

Werner

$38.30

-0.7 (-1.79%)

, USAK

USA Truck

$23.19

-3.3 (-12.46%)

04:55
05/23/18
05/23
04:55
05/23/18
04:55
Conference/Events
Wolfe Research to hold a conference »

11th Annual Global…

WERN

Werner

$38.30

-0.7 (-1.79%)

USAK

USA Truck

$23.19

-3.3 (-12.46%)

LKQ

LKQ Corp.

$30.14

-0.62 (-2.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 12

    Jun

  • 13

    Jun

  • 20

    Jun

AGS

PlayAGS

$22.83

-0.21 (-0.91%)

, BYD

Boyd Gaming

$36.45

-0.54 (-1.46%)

04:55
05/23/18
05/23
04:55
05/23/18
04:55
Conference/Events
SunTrust to hold a bus tour »

Casino Bus tour travels…

AGS

PlayAGS

$22.83

-0.21 (-0.91%)

BYD

Boyd Gaming

$36.45

-0.54 (-1.46%)

CZR

Caesars

$12.65

-0.2 (-1.56%)

RRR

Red Rock Resorts

$34.09

-0.54 (-1.56%)

LGND

Ligand

$187.19

1.95 (1.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.